Cargando…
Lumpy skin disease in Kazakhstan
This study describes the registration of the first cases of lumpy skin disease in July 2016 in the Republic of Kazakhstan. In the rural district of Makash, Kurmangazinsky district of Atyrau region, 459 cattle fell ill and 34 died (morbidity 12.9% and mortality 0.96%). To determine the cause of the d...
Autores principales: | Orynbayev, Mukhit B., Nissanova, Raikhan K., Khairullin, Berik M., Issimov, Arman, Zakarya, Kunsulu D., Sultankulova, Kulyaisan T., Kutumbetov, Lespek B., Tulendibayev, Ali B., Myrzakhmetova, Balzhan Sh., Burashev, Erbol D., Nurabayev, Sergazy S., Chervyakova, Olga V., Nakhanov, Aziz K., Kock, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884366/ https://www.ncbi.nlm.nih.gov/pubmed/33590351 http://dx.doi.org/10.1007/s11250-021-02613-6 |
Ejemplares similares
-
Mechanical Transmission of Lumpy Skin Disease Virus by Stomoxys spp. (Stomoxys calsitrans, Stomoxys sitiens, Stomoxys indica), Diptera: Muscidae
por: Issimov, Arman, et al.
Publicado: (2020) -
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters
por: Zhugunissov, Kuandyk, et al.
Publicado: (2021) -
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
por: Khairullin, Berik, et al.
Publicado: (2022) -
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
por: Nurpeisova, Ainur, et al.
Publicado: (2022) -
Genome Sequence of Atyrau-5BJN(IL18), a Recombinant Lumpy Skin Disease Virus with Knockout of Virulence Genes
por: Issabek, Aisha U., et al.
Publicado: (2022)